Skip to main content

8 Result(s)

within P Bramlage Remove this filter English Remove this filter

and

  1. No Access

    Article

    Impact of body weight on antidiabetic treatment and predictors of weight control under real-world conditions: a 2-year follow-up of DiaRegis cohort

    Treatment strategies for obese patients with type 2 diabetes mellitus aim to increase physical activity, reduce body weight, and improve glucose control using weight-beneficial antidiabetic drugs. The objecti...

    B. Hartmann, P. Bramlage, S. Schneider, D. Tschöpe, A. K. Gitt in Acta Diabetologica (2015)

  2. No Access

    Article

    The impact of age on the benefits and risks of aliskiren treatment: analyses of the 3A registry

    We aimed to analyze benefits and risks of aliskiren treatment in older adults (⩾65 years) in clinical practice. Patients (n=14 986) were assigned to either aliskiren (ALIS), an angiotensin-converting-enzyme inhib...

    S Friedrich, U Zeymer, R Dechend, I Hagedorn, T Riemer… in Journal of Human Hypertension (2015)

  3. No Access

    Article

    Percentile distribution of blood pressure readings in 35683 men and women aged 18 to 99 years

    The percentile distribution of blood pressure (BP) with regard to age, sex and cardiovascular risk factors is unknown. We aimed to provide epidemiological data for a comprehensive description of the BP distrib...

    C Balijepalli, C Lösch, P Bramlage, R Erbel, K H Humphries… in Journal of Human Hypertension (2014)

  4. No Access

    Article

    Treatment of hypertension in the elderly: data from an international cohort of hypertensives treated by cardiologists

    Hypertension in the elderly is a major risk factor for cardiovascular disease. We aimed to analyze determinants of blood pressure (BP) control across different age groups. Population of a large global survey o...

    M Thoenes, D Spirk, M Böhm, F Mahfoud, L Thevathasan… in Journal of Human Hypertension (2013)

  5. No Access

    Article

    Smoking is associated with a high prevalence of microalbuminuria in hypertensive high-risk patients: data from I-SEARCH

    Microalbuminuria (MAU) is a marker of endothelial dysfunction and a predictor of cardiovascular events. The effects of cigarette smoking on the prevalence of MAU in a high-risk population with arterial hyperte...

    Christian Ukena, F. Mahfoud, M. Kindermann, S. Gräber… in Clinical Research in Cardiology (2010)

  6. No Access

    Article

    Recognition and management of overweight and obesity in primary care in Germany

    BACKGROUND: In contrast to the well-documented high prevalence of overweight and obesity in the general population, the prevalence, recognition rates and management by primary care physicians—as the core gatekeep...

    P Bramlage, H-U Wittchen, D Pittrow, W Kirch, P Krause… in International Journal of Obesity (2004)

  7. No Access

    Article

    Regression of Microalbuminuria in Type 2 Diabetics after Switch to Irbesartan Treatment

    Objective: This study aimed to assess the blood pressure-lowering potency, renoprotective efficacy and safety of the angiotensin II type 1 (AT1)-receptor blocker irbesartan in monotherapy or in c...

    Prof. Dr H. Lehnert, P. Bramlage, D. Pittrow, W. Kirch in Clinical Drug Investigation (2004)

  8. No Access

    Article

    Patterns of antihypertensive drug utilization in primary care

    In the treatment of hypertension, physicians’ attitudes and practice patterns are receiving increased attention as contributors to poor blood pressure (BP) control. Thus, current use of antihypertensive drugs ...

    D. Pittrow, W. Kirch, P. Bramlage, H. Lehnert… in European Journal of Clinical Pharmacology (2004)